FDA Approves PCR-Based Companion Diagnostic for Keytruda
The assay identifies patients with microsatellite instability-high solid tumors who may be eligible for treatment with the immunotherapy.
Read MorePosted by CLP Edit Staff | Nov 12, 2026 | Amplification Technologies, Cancer |
The assay identifies patients with microsatellite instability-high solid tumors who may be eligible for treatment with the immunotherapy.
Read MorePosted by CLP Edit Staff | Nov 9, 2026 | Emerging & Zoonotic Diseases, Flu & Respiratory Infections |
CDC surveillance data show influenza activity higher than typical for early November, with Washington state public health laboratories confirming two new H5 infections.
Read MorePosted by CLP Edit Staff | Nov 6, 2026 | Anatomic Pathology, Digital Pathology, Melanoma |
Clinical studies found improved melanoma detection sensitivity, while a small US evaluation showed a 20% reduction in slide analysis time.
Read MorePosted by CLP Edit Staff | Nov 5, 2026 | Diabetes & Metabolic Diseases, Diagnostic Technologies, Molecular Diagnostics |
In a study of 229 patients, an AI-based liquid biopsy matched magnetic resonance elastography in identifying patients with fibrosis stages associated with eligibility for approved MASH treatments.
Read MorePosted by CLP Edit Staff | Nov 4, 2026 | Cancer, Molecular Diagnostics |
A real-world analysis of nearly 12,000 patients found that esophageal cell collection was successful in 95% of cases, with procedures taking less than two minutes on average.
Read More